GSK106 structure
|
Common Name | GSK106 | ||
|---|---|---|---|---|
| CAS Number | 1652591-82-6 | Molecular Weight | 437.97 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H28ClN5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK106GSK106 is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199[1]. |
| Name | GSK106 (hydrochloride) |
|---|---|
| Synonym | More Synonyms |
| Description | GSK106 is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H28ClN5O |
|---|---|
| Molecular Weight | 437.97 |
| Exact Mass | 437.198242 |
| InChIKey | VRPFLFUQMWOJAT-UHFFFAOYSA-N |
| SMILES | CCn1c(-c2nc3ccc(C(=O)N4CCCC(N)C4)cc3n2C)cc2ccccc21.Cl |
| (3-Amino-1-piperidinyl)[2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazol-6-yl]methanone hydrochloride (1:1) |
| GSK106 (hydrochloride) |
| (3-Aminopiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-6-yl)methanone hydrochloride |
| Methanone, (3-amino-1-piperidinyl)[2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazol-6-yl]-, hydrochloride (1:1) |